Home LiteratureArticle Details
PMID: 201214 Published · ppublish English Journal Article

Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections.

Antimicrobial agents and chemotherapy ·Vol. 12 ·No. 6 ·1977-12-00 ·Pages 655-9

Ostenson RC, Fields BT, Nolan CM

Abstract

Polymyxin B and rifampin were given to 12 patients with multi-drug-resistant nosocomial Serratia marcescens infections. Eight cures were achieved; drug hepatotoxicity occurred once; one fatal suprainfection was encountered; and two patients died during therapy of causes related to severe underlying illnesses. Polymyxin B and rifampin were uniformly synergistic in vitro against the infecting strains and against 40 additional clinical isolates of S. marcescens.

MeSH Terms
Adult Aged Drug Resistance, Microbial Enterobacteriaceae Infections/drug therapy Female Humans Male Middle Aged Polymyxin B/administration & dosage,pharmacology Polymyxins/administration & dosage Rifampin/administration & dosage,pharmacology Serratia marcescens/drug effects
Chemicals
Polymyxins Polymyxin B Rifampin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ostenson R C
Fields B T
Nolan C M
References (12)
12 references, click to expand
  1. Detection of Serratia outbreaks in hospital.
    Lancet. 1976 Aug 28;2(7983):455-9 PMID: 73753
  2. Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia.
    Lancet. 1977 Mar 5;1(8010):537-8 PMID: 65626
  3. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
    Am J Med. 1977 Jun;62(6):902-10 PMID: 326046
  4. The polymyxins.
    Med Clin North Am. 1970 Sep;54(5):1257-65 PMID: 4319624
  5. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
    Lancet. 1976 Mar 13;1(7959):580-3 PMID: 55850
  6. Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections.
    Antimicrob Agents Chemother. 1976 Feb;9(2):201-7 PMID: 178273
  7. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
    Antimicrob Agents Chemother. 1975 Jun;7(6):874-6 PMID: 168807
  8. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia.
    J Infect Dis. 1969 Jun;119(6):597-624 PMID: 4893892
  9. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    J Lab Clin Med. 1975 Nov;86(5):853-62 PMID: 810533
  10. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
    Ann Intern Med. 1975 Oct;83(4):484-8 PMID: 1101761
  11. Emergence of resistance to amikacin during treatment of burn wounds: the role of antimicrobial susceptibility testing.
    Surgery. 1976 Feb;79(02):224-8 PMID: 1246678
  12. Amikacin therapy for serious gram-negative bacillary infections.
    Ann Intern Med. 1975 Dec;83(6):790-800 PMID: 1200524
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1977-12-00
Pages
655-9
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC429999
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com